Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q1 2026 (March 31)7holders −2
2new positions
4sold out
$0.12avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, down 2 from Q4 2025. 2 opened new positions and 4 sold out. The largest holders were Boothbay Fund Management, LLC ($313K), Toronto Dominion Bank ($48K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($5K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $641 |
| Exits | 4 | $577 |
All 13F filers, Q4 2025 → Q1 2026: 29,239 shares bought and 56,342 shares sold, net −27,103 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Boothbay Fund Management, LLC | — | No change | 357,447 | $313K |
| Toronto Dominion Bank | — | Reduce -1.4% | 2,174,782 | $48K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $5K |
| Walleye Capital LLC | — | No change | 200,000 | $4K |
| Susquehanna International Group, LLP | — | New | 28,200 | $618 |
| Wolverine Asset Management LLC | — | New | 1,039 | $23 |
| IFP Advisors, Inc | — | No change | 50 | $1 |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.